Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Chronic Renal Failure

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    February 2024
  1. AMJAD W, Ginzberg SP, Passman JE, Heintz J, et al
    Predictive Risk Score for Postparathyroidectomy Hungry Bone Syndrome in Patients With Secondary Hyperparathyroidism.
    J Clin Endocrinol Metab. 2024;109:603-610.
    PubMed     Abstract available



  2. Correction to "Hemoglobin Glycation Index: A Novel Risk Factor for Incident Chronic Kidney Disease in an Apparently Healthy Population".
    J Clin Endocrinol Metab. 2024 Feb 8:dgae066. doi: 10.1210.
    PubMed    


    December 2023
  3. BIOLETTO F, Barale M, Maiorino F, Pusterla A, et al
    Trabecular bone score as a marker of skeletal fragility across the spectrum of chronic kidney disease: a systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2023 Dec 11:dgad724. doi: 10.1210.
    PubMed     Abstract available


    November 2023
  4. LI S, Cui M, Liu Y, Liu X, et al
    Metabolic profiles of type 2 diabetes and their association with renal complications.
    J Clin Endocrinol Metab. 2023 Nov 2:dgad643. doi: 10.1210.
    PubMed     Abstract available


  5. NAKASONE Y, Miyakoshi T, Sakuma T, Toda S, et al
    Hemoglobin Glycation Index, A Novel Risk Factor for Incident Chronic Kidney Disease in Apparently Healthy Population.
    J Clin Endocrinol Metab. 2023 Nov 1:dgad638. doi: 10.1210.
    PubMed     Abstract available


    October 2023
  6. OU SH, Chang WC, Wu LY, Wang SI, et al
    Diabetic macular oedema is predictive of renal failure in patients with diabetes mellitus and chronic kidney disease.
    J Clin Endocrinol Metab. 2023 Oct 6:dgad581. doi: 10.1210.
    PubMed     Abstract available


    August 2023
  7. HUANG PS, Cheng JF, Chen JJ, Wang YC, et al
    Higher Risk of Incident Hyperthyroidism in Patients With Atrial Fibrillation.
    J Clin Endocrinol Metab. 2023 Aug 11:dgad448. doi: 10.1210.
    PubMed     Abstract available


    May 2023
  8. FRANCHI M, Gunnarsson J, Gonzales-Parra E, Ferreira A, et al
    Paricalcitol and Extended Release Calcifediol for Treatment of Secondary Hyperparathyroidism in Non-Dialysis Chronic Kidney Disease: Results From a Network Meta-Analysis.
    J Clin Endocrinol Metab. 2023 May 26:dgad289. doi: 10.1210.
    PubMed     Abstract available


  9. RHEE CM, You AS, Narasaki Y, Brent GA, et al
    Development and Validation of a Prediction Model for Incident Hypothyroidism in a National Chronic Kidney Disease Cohort.
    J Clin Endocrinol Metab. 2023 May 15:dgad261. doi: 10.1210.
    PubMed     Abstract available


    March 2023
  10. OIWA A, Hiwatashi D, Takeda T, Miyamoto T, et al
    Efficacy and safety of low-dose spironolactone for chronic kidney disease in type 2 diabetes.
    J Clin Endocrinol Metab. 2023 Mar 14:dgad144. doi: 10.1210.
    PubMed     Abstract available


    December 2022
  11. HAN Q, Xu H
    Letter to the Editor from Han and Xu "Association between DPP4 inhibitor use and the incidence of cirrhosis, ESRD, and some cancers in patients with diabetes".
    J Clin Endocrinol Metab. 2022 Dec 8:dgac693. doi: 10.1210.
    PubMed    


  12. LEE DH
    "Response to Letter to the Editor from Han and Xu: Association between DPP4 inhibitor use and the incidence of cirrhosis, ESRD, and some cancers in patients with diabetes".
    J Clin Endocrinol Metab. 2022 Dec 7:dgac697. doi: 10.1210.
    PubMed    


  13. JORGENSEN HS, Evenepoel P, Komaba H, Mazzaferro S, et al
    Response to Letter to the Editor from Sumi et al: "Lower bone turnover and skeletal PTH responsiveness in Japanese compared to European patients receiving hemodialysis".
    J Clin Endocrinol Metab. 2022 Dec 5:dgac698. doi: 10.1210.
    PubMed    


  14. SUMI H, Shiizaki K, Tominaga N
    Letter to the Editor from Sumi et al: "Lower bone turnover and skeletal PTH responsiveness in Japanese compared to European patients receiving hemodialysis".
    J Clin Endocrinol Metab. 2022 Dec 5:dgac696. doi: 10.1210.
    PubMed    


    September 2022
  15. NA Y, Kim SW, Park IB, Choi SJ, et al
    Association between DPP4 inhibitor use and the incidence of cirrhosis, ESRD, and some cancers in patients with diabetes.
    J Clin Endocrinol Metab. 2022 Sep 15. pii: 6701630. doi: 10.1210.
    PubMed     Abstract available


  16. EVENEPOEL P, Jorgensen HS, Komaba H, Mazzaferro S, et al
    Lower bone turnover and skeletal PTH responsiveness in Japanese compared to European patients on hemodialysis.
    J Clin Endocrinol Metab. 2022 Sep 6. pii: 6692465. doi: 10.1210.
    PubMed     Abstract available


    June 2022
  17. SUN Y, Hong L, Huang Z, Wang L, et al
    Fibrosis Risk in Nonalcoholic Fatty Liver Disease is Related to Chronic Kidney Disease in Aged Type 2 Diabetes Patients.
    J Clin Endocrinol Metab. 2022 Jun 29. pii: 6619454. doi: 10.1210.
    PubMed     Abstract available


    May 2022
  18. LASTER ML, Rowan B, Chen HC, Schwantes-An TH, et al
    Genetic Variants Associated with Mineral Metabolism Traits in Chronic Kidney Disease.
    J Clin Endocrinol Metab. 2022 May 19. pii: 6588679. doi: 10.1210.
    PubMed     Abstract available


    March 2022
  19. AU PCM, Tan KCB, Cheung BMY, Wong ICK, et al
    Association between SGLT2 Inhibitors vs DPP4 Inhibitors and Renal Outcomes Among Patients with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2022 Mar 18. pii: 6550649. doi: 10.1210.
    PubMed     Abstract available


  20. KOMABA H, Hamano T, Fujii N, Moriwaki K, et al
    Parathyroidectomy versus cinacalcet among patients undergoing hemodialysis.
    J Clin Endocrinol Metab. 2022 Mar 12. pii: 6547683. doi: 10.1210.
    PubMed     Abstract available


    January 2022
  21. WALLACE AS, Chang AR, Shin JI, Reider J, et al
    Obesity and Chronic Kidney Disease in US Adults With Type 1 and Type 2 Diabetes Mellitus.
    J Clin Endocrinol Metab. 2022 Jan 26. pii: 6511824. doi: 10.1210.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.